Price Alert

GE HealthCare Technologie... (GEHCV)

NASDAQ: GEHCV · Real-Time Price · USD

56.00

-2.38 (-4.08%)

At close: Jan 04, 2023, 6:00 AM

GE HealthCare Statistics

Share Statistics

GE HealthCare has 454.71M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	454.71M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	362.96M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 12, so 0% of the outstanding shares have been sold short.

Short Interest	12
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is 17.89 and the forward PE ratio is null. GE HealthCare's PEG ratio is 0.41.

PE Ratio	17.89
Forward PE	n/a
PS Ratio	1.81
Forward PS	n/a
PB Ratio	4.22
P/FCF Ratio	23
PEG Ratio	0.41

Financial Ratio History

Enterprise Valuation

GE HealthCare has an Enterprise Value (EV) of 42.15B.

EV / Sales	2.14
EV / EBITDA	11.5
EV / EBIT	21.61
EV / FCF	27.19

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 1.11.

Current Ratio	1.04
Quick Ratio	0.83
Debt / Equity	1.11
Debt / EBITDA	2.56
Debt / FCF	6.05
Interest Coverage	5.2

Financial Efficiency

Return on Equity is 23.6% and Return on Invested Capital is 8.29%.

Return on Equity	23.6%
Return on Assets	6.02%
Return on Invested Capital	8.29%
Revenue Per Employee	$385.73K
Profits Per Employee	$39.08K
Employee Count	51,000
Asset Turnover	0.59
Inventory Turnover	5.91

Taxes

Income Tax	531M
Effective Tax Rate	20.57%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 0, so GE HealthCare's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	4,149,288

Income Statement

In the last 12 months, GE HealthCare had revenue of 19.67B and earned 1.99B in profits. Earnings per share was 4.37.

Revenue	19.67B
Gross Profit	8.21B
Operating Income	2.63B
Net Income	1.99B
EBITDA	3.67B
EBIT	3.09B
Earnings Per Share (EPS)	4.37

Full Income Statement

Balance Sheet

The company has 2.87B in cash and 9.38B in debt, giving a net cash position of -6.5B.

Cash & Cash Equivalents	2.87B
Total Debt	9.38B
Net Cash	-6.5B
Retained Earnings	3.26B
Total Assets	35.5B
Working Capital	-140M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.95B and capital expenditures -401M, giving a free cash flow of 1.55B.

Operating Cash Flow	1.95B
Capital Expenditures	-401M
Free Cash Flow	1.55B
FCF Per Share	3.4

Full Cash Flow Statement

Margins

Gross margin is 41.71%, with operating and profit margins of 13.34% and 10.13%.

Gross Margin	41.71%
Operating Margin	13.34%
Pretax Margin	13.12%
Profit Margin	10.13%
EBITDA Margin	18.64%
EBIT Margin	13.34%
FCF Margin	7.88%

Dividends & Yields

GEHCV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	5.59%
FCF Yield	4.35%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for GEHCV.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$21.85
Lynch Upside	-60.98%
Graham Number	42.68
Graham Upside	-23.79%

Scores

Altman Z-Score	1.59
Piotroski F-Score	4